Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The central descending serotonergic pain-modulating pathway is a fundamental neural circuit responsible for the top-down regulation of nociceptive processing (Ossipov et al., 2014, Nature Reviews Neuroscience). Originating primarily from the nucleus raphe magnus within the rostral ventromedial medulla (RVM), these serotonergic neurons project to the spinal cord's dorsal horn to modulate incoming pain signals (Bannister & Dickenson, 2016, Curr Opin Support Palliat Care). The pathway is unique in its bidirectional nature; it can either inhibit pain (antinociception) via 5-HT1 receptors or facilitate pain (pro-nociception) via 5-HT2 or 5-HT3 receptors (StatPearls, 2023, Physiology, Pain). In chronic pain conditions like fibromyalgia or neuropathic pain, there is often a shift toward descending facilitation or a loss of descending inhibition (Nature Reviews Neuroscience, 2014). Many analgesic drugs, such as Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Tricyclic Antidepressants (TCAs), exert their effects by increasing serotonin levels in the spinal synapse to reinforce these inhibitory controls (Marks et al., 2009, Current Neuropharmacology). Consequently, this pathway serves as a major focus for pharmacological and neuromodulatory therapies aimed at restoring normal pain processing.
Potentiation of descending inhibitory signals through the inhibition of serotonin reuptake, increasing synaptic serotonin availability in the spinal dorsal horn to activate inhibitory receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central descending serotonergic pain-modulating pathway.